POTASSIUM CITRATE
- Product NDC
- 71335-2871
- 11-digit product format
- 713352871
- Labeler code
- 71335
- Product ID
- 71335-2871_41d8fb94-18b5-a16b-e063-6394a90aee3d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- POTASSIUM CITRATE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA206813
- Marketing category
- ANDA
- Marketing start
- 2017-11-01
- Substance
- POTASSIUM CITRATE
- Active strength
- 10 meq/1
- Pharmacologic classes
- Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- POTASSIUM CITRATE
- Brand name suffix
- EXTENDED RELEASE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| POTASSIUM CITRATE | 10 meq/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | EE90ONI6FF |
| Rxcui | 199381 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-2871-1 | POTASSIUM CITRATEEXTENDED RELEASE | 100 in 1 BOTTLE | TABLET | 100 | | 100 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-2871-1 | 71335287101 | 100 TABLET in 1 BOTTLE (71335-2871-1) | 100 tablet | 2025-10-23 | No | No | Current |